US Health Secretary Robert F. Kennedy Jr announced the dismissal of all members of the Advisory Committee on Immunization Practices on Monday. The move removes 17 experts from the federal vaccine advisory panel citing alleged conflicts of interest. Kennedy stated the decision aims to restore public trust in immunization policies across the nation.
The announcement appeared in a Wall Street Journal op-ed alongside an official Department of Health and Human Services press release. Kennedy claimed the committee had been compromised by financial ties to pharmaceutical companies. He asserted that unbiased science must guide recommendations without industry influence or bias.
Senate Democratic Leader Chuck Schumer criticized the action as a wrecking ball against safety programs. He warned that the committee risks filling with individuals suspicious of vaccines rather than experts. Republican Senator Bill Cassidy expressed concern during his confirmation vote process regarding the Secretary.
Cassidy noted he spoke directly with the Secretary to ensure medical expertise remains central. Pediatrician Paul Offit, who served on the panel from 1998 to 2003, offered sharp criticism of the strategy. Offit told AFP that the Secretary believes anyone supporting vaccines is deeply in the pocket of industry.
Susan Kressly, president of the American Academy of Pediatrics, described the move as silencing independent medical expertise. She stated the administration is stoking distrust in lifesaving vaccines through this administrative action. The removal targets all members appointed under former president Joe Biden.
Kennedy previously chaired a nonprofit that discouraged routine childhood immunizations and amplified false claims. He linked the measles, mumps and rubella vaccine to autism in past statements. His tenure includes curtailing access to Covid-19 shots and raising fears around immunization.
The United States currently faces its worst measles outbreak in years with three reported deaths. More than 1,100 confirmed cases exist though experts warn the true count is likely far higher. Experts question how the country can trust people selected by the Secretary for future recommendations.
Offit recalled how several states formed independent vaccine advisory panels during the first Trump term. That administration pressured federal health agencies to approve vaccines ahead of the 2020 election. This fragmentation could occur again if confidence in federal guidance erodes further.
The Advisory Committee on Immunization Practices is scheduled to meet at the Centers for Disease Control and Prevention in Atlanta. The gathering will occur from June 25 to June 27 at the organization headquarters. Vaccines for anthrax and respiratory syncytial virus are on the agenda.
Health agencies face significant scrutiny regarding how they select members for future advisory roles. The administration must demonstrate that new appointments lack the conflicts they cited in the announcement. Public confidence in the national immunization strategy hangs in the balance following this decision.
